Financial Ratios | Vivimed Labs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY14529.15  -568.20 (-3.76%)
SENSEX49099.99  -1939.32 (-3.80%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

VIVIMED LABS LTD.

NSE : VIVIMEDLABBSE : 532660ISIN CODE : INE526G01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE15.45-0.25 (-1.59 %)
PREV CLOSE (Rs.) 15.70
OPEN PRICE (Rs.) 15.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 139848
TODAY'S LOW / HIGH (Rs.)15.20 16.05
52 WK LOW / HIGH (Rs.)6.5 23.62
NSE15.55-0.1 (-0.64 %)
PREV CLOSE( Rs. ) 15.65
OPEN PRICE (Rs.) 15.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 15.55 (3617)
VOLUME 727872
TODAY'S LOW / HIGH(Rs.) 15.15 16.10
52 WK LOW / HIGH (Rs.)6.2 23.35

Financial Ratios

Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)-13.166.959.4426.4151.64
   CEPS(Rs)-5.0915.0416.0633.6017.90
   DPS(Rs)0.000.000.400.400.00
   Book NAV/Share(Rs)56.8570.35104.6085.93321.01
   Tax Rate(%)0.3313.1411.2225.3116.27
Margin Ratios
   Core EBITDA Margin(%)0.6212.8416.9327.6716.57
   EBIT Margin(%)-4.5810.3514.1724.2313.76
   Pre Tax Margin(%)-10.345.027.2319.607.43
   PAT Margin (%)-10.314.366.4214.646.22
   Cash Profit Margin (%)-3.989.4411.1818.6210.78
Performance Ratios
   ROA(%)-4.832.443.4310.444.25
   ROE(%)-20.757.959.7635.1816.50
   ROCE(%)-2.697.039.0421.8611.93
   Asset Turnover(x)0.470.560.530.710.68
   Sales/Fixed Asset(x)0.871.151.161.130.82
   Working Capital/Sales(x)5.173.852.415.285.72
Efficiency Ratios
   Fixed Capital/Sales(x)1.150.870.860.881.21
   Receivable days104.3187.6473.2065.7188.94
   Inventory Days183.67153.18157.64121.69125.08
   Payable days92.0579.6670.9060.7660.42
Valuation Parameters
   PER(x)0.003.377.524.031.61
   PCE(x)-1.431.564.423.174.64
   Price/Book(x)0.130.330.681.241.29
   Yield(%)0.000.000.560.380.00
   EV/Net Sales(x)1.211.051.381.241.23
   EV/Core EBITDA(x)69.076.797.294.416.72
   EV/EBIT(x)-26.3710.129.745.138.95
   EV/CE(x)0.580.590.690.880.81
   M Cap / Sales0.060.150.490.590.50
Growth Ratio
   Net Sales Growth(%)-19.4910.92-18.908.64-2.50
   Core EBITDA Growth(%)-90.88-9.62-45.5967.307.25
   EBIT Growth(%)-135.60-19.01-52.5691.3013.10
   PAT Growth(%)-290.21-24.61-64.44155.7316.13
   EPS Growth(%)-289.32-26.40-64.24-48.8516.13
Financial Stability Ratios
   Total Debt/Equity(x)1.181.050.691.451.63
   Current Ratio(x)1.271.381.621.341.26
   Quick Ratio(x)0.610.750.940.750.72
   Interest Cover(x)-0.791.942.045.232.17
   Total Debt/Mcap(x)15.664.941.411.171.41